CAMP

CAMP4 Therapeutics Corporation

Insider Trades

NameValueActionPriceLast Price
Young Richard ADirector
$25k15.2k shares
BuySep 11, 2025
$1.65
$4.49
Mandel-Brehm JoshDirector, Officer: Chief Executive Officer
$10.0k6.1k shares
BuySep 11, 2025
$1.65
$4.49
Gold KellyChief Financial Officer
$10.0k6.1k shares
BuySep 11, 2025
$1.65
$4.49
Maricich YuriChief Medical Officer
$10.0k6.1k shares
BuySep 11, 2025
$1.65
$4.49
Nashat AmirDirector, 10 Percent Owner:
$131k85.5k shares
BuySep 11, 2025
$1.53
$4.49
Nashat AmirDirector, 10 Percent Owner:
$1.9M1.2M shares
BuySep 11, 2025
$1.53
$4.49

News

globenewswire.comNew Analysis Strengthens Mercator Gold System and Confirms High-Grade BIF Continuityglobenewswire.comJun 8thenewswire.comMercator Gold Exploration Priorities & Strategythenewswire.comMay 26globenewswire.comCAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)globenewswire.comMay 21globenewswire.comCAMP4 Therapeutics to Present New Preclinical Data Demonstrating CMP-002 Improves Seizure Threshold and Severity in a Model of SYNGAP1-Related Disorderglobenewswire.comMay 14zacks.comCAMP4 Therapeutics Corporation (CAMP) Reports Q1 Loss, Lags Revenue Estimateszacks.comMay 7